menu
    • menu
    [{"orgOrder":0,"company":"NIN Institute","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"INDIA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"NIN Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NIN Institute \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"NIN Institute \/ Undisclosed"},{"orgOrder":0,"company":"SC Fiterman Pharma SRL","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"ROMANIA","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"SC Fiterman Pharma SRL","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SC Fiterman Pharma SRL \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"SC Fiterman Pharma SRL \/ Undisclosed"},{"orgOrder":0,"company":"Technological Centre of Nutrition and Health, Spain","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"SPAIN","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"Technological Centre of Nutrition and Health, Spain","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Technological Centre of Nutrition and Health, Spain \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Technological Centre of Nutrition and Health, Spain \/ Undisclosed"},{"orgOrder":0,"company":"Atlas Biomed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2019","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Atlas Biomed","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Powder","sponsorNew":"Atlas Biomed \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Atlas Biomed \/ Undisclosed"},{"orgOrder":0,"company":"Imperial College London","sponsor":"Biotechnology and Biological Sciences Research Council | Nestle Health Sciences SA","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Imperial College London","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Imperial College London \/ Biotechnology and Biological Sciences Research Council | Nestle Health Sciences SA","highestDevelopmentStatusID":"1","companyTruncated":"Imperial College London \/ Biotechnology and Biological Sciences Research Council | Nestle Health Sciences SA"},{"orgOrder":0,"company":"Nixol","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Apple Cider Vinegar Extract","moa":"||Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Approved FDF","graph3":"Nixol","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Nixol \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Nixol \/ Undisclosed"},{"orgOrder":0,"company":"Yale University","sponsor":"VA Connecticut Healthcare System | National Center for Complementary and Integrative Health","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Inulin","moa":"Insulin (INS)","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"Yale University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Sachet","sponsorNew":"Yale University \/ VA Connecticut Healthcare System | National Center for Complementary and Integrative Health","highestDevelopmentStatusID":"8","companyTruncated":"Yale University \/ VA Connecticut Healthcare System | National Center for Complementary and Integrative Health"}]

    Find Clinical Drug Pipeline Developments & Deals for Inulin

    Menu

    Inulin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Yale University

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Yale University

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase II

                            Sponsor : VA Connecticut Healthcare System | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            September 24, 2025

                            Lead Product(s) : Inulin

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase II

                            Sponsor : VA Connecticut Healthcare System | National Center for Complementary and Integrative Health

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Nixol

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Nixol

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Apple Cider Vinegar Extract,Guarana Extract,Inulin

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nixol Capsules Launch in the UK: A Natural Path to Weight Management and Metabolic Support

                            Details : Nixol, a plant-powered metabolic support supplement, is now available to individuals across the United Kingdom.

                            Product Name : Nixol Weight Loss Capsule

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 21, 2025

                            Lead Product(s) : Apple Cider Vinegar Extract,Guarana Extract,Inulin

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            NIN Institute

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            NIN Institute

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Agave Inulin on Constipation and Quality of Life in Peritoneal Dialysis Patients.

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            December 17, 2024

                            Lead Product(s) : Inulin

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Imperial College London

                            United Kingdom arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Imperial College London

                            United Kingdom arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Biotechnology and Biological Sciences Research Council | Nestle Health Sciences SA

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Investigation of the Effects of Dietary Fibres on the Gut Microbiome in a Transgenerational Cohort

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            May 06, 2022

                            Lead Product(s) : Inulin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Biotechnology and Biological Sciences Research Council | Nestle Health Sciences SA

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Atlas Biomed

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Atlas Biomed

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dietary Fibers Effect on the Gut Microbiota Composition

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Metabolic Syndrome.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            October 03, 2019

                            Lead Product(s) : Inulin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Technological Centre of Nutrition and Health, Spain

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Technological Centre of Nutrition and Health, Spain

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of the Consumption of an Enriched Surimi in Abdominal Visceral Adiposity

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Obesity, Abdominal.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            August 15, 2018

                            Lead Product(s) : Inulin

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            SC Fiterman Pharma SRL

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            SC Fiterman Pharma SRL

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inulin

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Inuline Supplement in Patients With Irritable Bowel Syndrome

                            Details : Inulin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 02, 2017

                            Lead Product(s) : Inulin

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth